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Influenza A virus is unique as an RNA virus in that it
replicates in the nucleus and undergoes splicing.
With only ten major proteins, the virus must gain
nuclear access, replicate, assemble progeny virions
in the cytoplasm, and then egress. In an effort to
elucidate the coordination of these events, we
manipulated the transcript levels from the bicis-
tronic nonstructural segment that encodes the
spliced virus product responsible for genomic
nuclear export. We find that utilization of an erro-
neous splice site ensures the slow accumulation of
the viral nuclear export protein (NEP) while gener-
ating excessive levels of an antagonist that inhibits
the cellular response to infection. Modulation of
this simple transcriptional event results in improp-
erly timed export and loss of virus infection.
Together, these data demonstrate that coordination
of the influenza A virus life cycle is set by a ‘‘molec-
ular timer’’ that operates on the inefficient splicing of
a virus transcript.INTRODUCTION
Influenza A virus (IAV) is a negative sense, nuclear RNA virus
comprised of eight viral segments encoding ten major proteins
(Palese and Shaw, 2006). Despite its simplicity, IAV manages
to usurp the necessary host components required for replication
and coordinates both its nuclear import and export to coincide
with virus replication and egress, respectively. Segment eight
of IAV is one of two viral RNAs that undergoes splicing and
thus encodes two proteins, nonstructural (NS) protein 1 (NS1)
and NS2 (herein referred to as the nuclear export protein
[NEP]) (Lamb and Lai, 1980; O’Neill et al., 1998). IAV initiates
transcription of the NS segment as a continuous product to
generate NS1, whereas a weak 50 splice site results in the
second, less abundant splice product, NEP, which accounts
for 10%–15% of NS-derived mRNA (Agris et al., 1989; Robb
et al., 2010).NS1 represents the dominant virus countermeasure to
antagonize the cellular response to infection (Hale et al.,
2008). NS1 has been described to inhibit a broad range of
cellular functions as well as interfere with host mRNA export
and splicing (Hale et al., 2008). The host antagonism function
of NS1 was perhaps best illustrated by studies finding that
IAV lacking NS1 was attenuated by more than four logs in vivo
but maintained wild-type virulence in mice lacking antiviral
signaling capability (Egorov et al., 1998; Garcı´a-Sastre et al.,
1998).
Unlike NS1, NEP performs a fundamental role directly pertain-
ing to the virus life cycle. NEP is a 14 kDa protein, composed
of 121 amino acids, and is necessary for the production of
replication-competent virus (Neumann et al., 2000). The critical
function of NEP is postulated to be in the nuclear export of
nucleoprotein-associated (NP) vRNAs (vRNPs) (Boulo et al.,
2007; Cros and Palese, 2003; O’Neill et al., 1998). NEP-medi-
ated export of vRNPs is orchestrated by its association with
the M1 matrix protein, which directly associates with the NP-
bound vRNA (Akarsu et al., 2003; Huang et al., 2001; Shimizu
et al., 2011; Yasuda et al., 1993; Ye et al., 1999). Disruption of
the nuclear export signal of NEP results in a complete loss of
virus replication (Iwatsuki-Horimoto et al., 2004; Neumann
et al., 2000). In addition to its role in vRNP export, NEP has
also been implicated in controlling the level of complementary
vRNA, in determining host tropism, and in the synthesis of
IAV-specific small virus RNA (Ma¨nz et al., 2012; Perez et al.,
2010, 2012; Robb et al., 2009).
In this report, we sought to define the interplay between the
products of the NS segment to determine whether the balance
of NS1 and NEP are critical for coordinating virus infection. To
achieve this, we used microRNA (miRNA) targeting to silence
NS1 without impacting NEP, and other modifications, to
generate viruses in which NEP levels were either elevated or
reduced independent of NS1. Surprisingly, we found that
silencing NS1 by greater than 90% does not impair the virus’s
ability to replicate and incapacitate the cell’s antiviral response.
In contrast, modulating the levels of NEP resulted in virus atten-
uation as a result of improperly timed vRNP export. Taken
together, these data illustrate how IAV utilizes an inefficient
splice site to slowly accumulate NEP as a byproduct of tran-
scribing NS1, and implicates this process as a molecular timer
that coordinates virus infection.Cell Reports 3, 23–29, January 31, 2013 ª2013 The Authors 23
Figure 1. Silencing of NS1 Does Not Impact
Virus Replication In Vitro
(A–C) Western blot analysis of whole-cell extract
(WCE) derived from (A) Jurkat T cells, (B) murine
embryonic fibroblasts (MEFs), and (C) MEFs defi-
cient in Dicer1 (Dicer1/) infected with Scbl, 20T,
and 142T viruses. Immunoblots depict NP, NS1,
NEP, and actin.
(D) Multicycle growth curves performed in A549
cells in response to Scbl, 20T, 142T, and delNS1
IAV strains. Error bars represent average ± SD of
the mean of samples from independent growth
curves analyzed in triplicate. LD, limit of detection.
See also Figure S1.RESULTS
Selective Silencing of NS1 through miRNA-Mediated
Targeting
In an effort to selectively target NS1 without impacting the levels
of NEP,we chose to harness the activity of endogenousmiRNAs,
a technique previously demonstrated to be successful for IAV
(Langlois et al., 2012; Perez et al., 2009; Varble et al., 2010).
For this purpose, we chose to exploit the ubiquitous expression
of miR-20 to silence NS1 during virus infection. In addition, we
engineered a second virus in which NS1 was targeted by the
cell-specific expression of miR-142, which would limit expres-
sion only in hematopoietic cells (Langlois et al., 2012). Expres-
sion patterns of miR-20 and miR-142 have been described
elsewhere but were independently verified for the relevant
tissues and cells used in this study (Figure S1A) (Landgraf
et al., 2007). To silence NS1, we inserted a scrambled (Scbl)
sequence or tandem targets (T) of miR-20 or miR-142 into the
30 untranslated region (UTR) of a modified NS viral vector (Fig-
ure S1B) (Varble et al., 2010). Perfect complementarity to either
miRNA conferred sequence-specific silencing of NS1 at both
a protein and mRNA level (Figure S1C). Plasmid-based rescue
using each of these constructs resulted in the generation of three
isogenic viruses (herein referred to as Scbl, 20T, and 142T)
differing only in the NS1 30 UTR. In order to confirmNS1 silencing
of the recombinant IAV strains, we infected cells expressing
different miRNA profiles. In hematopoietic cells, expressing
high levels of both miR-20 and miR-142, silencing of NS1 was
robust, generating no detectable NS1 at 8 hr following infection24 Cell Reports 3, 23–29, January 31, 2013 ª2013 The Authorswith either 20T or 142T IAV strains (Fig-
ure 1A). In contrast to hematopoietic cells,
infection of nonhematopoietic lineages
demonstrated NS1 silencing only in
response to the 20T strain (Figure 1B).
Silencing of NS1 was confirmed to be
miRNA specific, because virus infection
in cells lacking Dicer1 yielded comparable
levels of NS1 among Scbl, 20T, and
142T infections (Figure 1C). Moreover,
these data demonstrate that independent
of NS1 targeting, NP and NEP levels
remain unaffected regardless of cell type
or miRNA expression (Figures 1A–1C).Taken together, we conclude that the engineered NS segment
can be used to successfully target NS1 by host miRNAs without
impacting NEP expression in the context of a replication-compe-
tent IAV.
Silencing of NS1 Does Not Impact Virus Replication
In Vitro
In an effort to characterize the consequences of NS1 silencing
as it pertained to virus replication and the host response, we
performed multicycle growth curves on the three recombinant
viruses. Nonhematopoietic lung epithelial cells were treated
with Scbl, 20T, or 142T IAV strains or an IAV lacking NS1
(delNS1). Assaying for virus replication demonstrated that
delNS1 infection was substantially inhibited, whereas Scbl,
20T, and 142T strains all accumulated to high levels of 10E7
plaque forming units (pfu) per milliliter (Figure 1D). To ascertain
the extent of NS1 silencing and the cellular response to virus
infection, we analyzed both IAV expression and induction of
the IFN-I-dependent transcript, Mx1 (Haller et al., 1979; Staeheli
et al., 1986). In agreement with published reports, infection of the
delNS1 virus demonstrated no NS1 and a dramatic decrease in
both NP and NEP levels (Figure S1D) (Garcı´a-Sastre et al., 1998).
Furthermore, complete deletion of NS1 resulted in elevated in-
duction of Mx1. In contrast to delNS1, infection of the 20T IAV
strain revealed a significant decrease in NS1 but no change in
the expression of NP, NEP, or Mx1, suggesting that low levels
of NS1 are sufficient to antagonize the cellular response in vitro.
Given the efficient nature of viruses, we reasoned that there
must be a biological requirement for sustained expression of
Figure 2. Low Levels of NS1 Are Sufficient
for Virus Replication In Vivo
(A and B) Western blot analysis of WCE from (A)
pLFs or (B) BMDMs from wild-type (WT) C57BL/6
mice infected with Scbl, 20T, or 142T IAV, or mock
(M) treated for 24 hr.
(C and D) Western blot analysis of (C) Ifnar1//
Il28r/ or (D) WT mouse lungs infected intrana-
sally with either Scbl, 20T, or 142T IAV or mock (M)
treated at 48 hpi. Immunoblots depict NP, NS1,
and actin.
(E) Viral titers from WT C57BL/6 mice infected
with Scbl, 20T, or 142T, or mock (PBS) treated.
Data points represent individual mice assayed in
triplicate.
See also Figure S2.NS1. One hypothesis for the lack of an in vitro phenotype is that
low-level production of NS1 was sufficient in immortalized cells,
whereas sustained and elevated levels may be necessary in
primary cultures where interferon signaling is unperturbed (Stojdl
et al., 2003). To test this hypothesis, we characterized Scbl, 20T,
and 142T IAV strains in primary lung fibroblasts (pLFs) and bone
marrow-derived macrophages (BMDMs) (Figures 2A and 2B).
Infection of pLFs, which demonstrate robust levels of miR-20
and low levels of miR-142 (a possible result of resident macro-
phages), showed no substantial difference in the expression of
NP among IAV strains (Figure 2A). However, in agreement with
our in vitro data, NS1 levels in lung fibroblast cultures were
inversely proportional to endogenous miRNA levels. Further-
more, comparable experiments in BMDMs also showed a sub-
stantial loss of NS1 without impacting NP in both 20T and
142T infections (Figure 2B). Together, these data corroborate
our in vitro findings that low levels of NS1 expression are suffi-
cient to allow for optimal replication.
To ascertain whether the dramatic loss of NS1 impacted the
course of an in vivo virus infection, we compared Scbl, 20T,
and 142T IAV strains in the context of an animal model. To first
ensure that NS1 targeting was robust in vivo, we infected mice
devoid of interferon signaling, in which loss of NS1 function
would be of little consequence, and analyzed whole lung for
viral protein expression (Figure 2C). In agreement with both
in vitro and ex vivo data, silencing of the 20T virus was robust,
demonstrating a complete loss of detectable NS1 with little
to no impact on NP expression. Successful silencing of NS1
in vivo could also be corroborated in wild-type interferon
competent mice (Figure 2D). Having confirmed in vivo target-
ing, we administered a sublethal dose of Scbl, 20T, and 142T
IAV strains to wild-type mice to determine the host responseCell Reports 3, 23–2to infection. Surprisingly, the viruses
demonstrated no substantial difference
in overall virus titers, reaching levels
between 10E5 pfu/ml and 10E6 pfu/ml
(Figure 2E). Similarly, the host response,
as measured by two interferon-regulated
genes, IFN stimulated gene 15 (ISG15)
and IFN regulatory factor 7 (IRF7),
demonstrated no substantial differenceacross viral cohorts (Figures S2A and S2B). These results
suggest that low levels of NS1 are sufficient to antagonize the
cellular response to infection and permit high levels of virus
replication in vivo.
NEP Accumulation Defines Virus Replication Levels
In an effort to understand the molecular basis for sustained NS
transcription, we investigated the properties of the less abun-
dant transcript of segment eight, NEP. To determine whether
the intracellular concentration of NEP demonstrated comparable
flexibility with regards to function as that observed for NS1,
we monitored virus replication in model systems that either
decreased or enhanced NEP levels. First, we utilized a recombi-
nant virus in which NEP expression was controlled by a porcine
teschovirus-1 2A ribosome ‘‘stop-carry on’’ recoding site rather
than being a spliced product of NS1 (Figure S3A) (Manicassamy
et al., 2010). This virus, herein referred to as IAV 2A, while
producing sufficient levels of NS1 (fused to green fluorescent
protein), demonstrated a significant decrease in NEP (Figure 3A).
Consequently, IAV 2A virus, when compared to a wild-type
parental strain, resulted in a two log decrease of progeny virions,
suggesting that insufficient NEP impaired replication despite
normal protein synthesis of structural proteins such as NP
(Figures 3A and 3B). To ensure the 2A phenotype was a result
of decreased NEP expression, we also verified the impact on
virus titers in the context of a wild-type infection treated with
short interfering RNAs (siRNAs) against NEP. To this end, we
used two siRNAs with differing NEP silencing capacities (NEP1
and NEP2) to reduce, but not eliminate, NEP expression during
IAV infection (Figure S3B). Comparable to the replication defect
of IAV 2A, wild-type IAV infections treated with siRNAs
against NEP resulted in a significant decrease in viral titers,9, January 31, 2013 ª2013 The Authors 25
Figure 3. NEP Is Essential in Determining
the Levels of Virus Replication
(A) Western blot analysis of WCE from fibroblasts
infected with either WT or 2A viruses or mock
treated for 3, 6, 9, or 12 hr postinfection (HPI).
(B) Multicycle growth curve for WT and 2A IAV.
(C) Western blot analysis of WCE from fibroblasts
infected with VLVs containing either an extragenic
scrambled (Scbl) sequenceorNEPonsegment four.
(D) Multicycle growth curve of WT IAV coinfected
with VLVs characterized in (C).
(A and C) Immunoblots depict NP, NS1, NEP, and
actin.
(BandD)Errorbars representmean±SDof themean
of samples from independent multicycle growth
curve analyzed in triplicate. LD, limit of detection.
See also Figure S3.demonstrating a one log attenuation at 48 hr postinfection (hpi;
p = 0.01) (Figure S3C).
To ascertain whether excess NEP was also detrimental to
overall virus replication, we designed a replication-incompetent
IAV-like vector (VLV) that encoded an additional copy of NEP
(VLV NEP) (Figure S3D). As a negative control, we also generated
a VLV that expressed a scrambled noncoding RNA (VLV Scbl)
(Figure S3D). VLVs expressing the extragenomic NEP and Scbl
segments were grafted into segment four (which normally en-
codes hemagglutinin [HA]) and propagated in HA-expressing
cells (Figure S3D). VLVs grew to high titers and could be used
to transduce cells to express all of the IAV genes minus HA in
addition to either the noncoding RNA (VLV Scbl) or high levels
of NEP (VLV NEP). Treatment of cells with the VLVs resulted in
robust levels of NP and NS1 within 24 hr and, in response to
VLV NEP, high levels of NEP (Figure 3C). Given the nature of
IAV to exchange segments through antigenic shift, we then per-
formed an infection at a highmultiplicity of infection mixing either
VLV Scbl or NEP with wild-type virus. Monitoring replication at
12 hr intervals for 48 hr demonstrated that, while treatment
with VLV Scbl permitted sustained levels of virus replication,
an overabundance of NEP resulted in a two log attenuation (Fig-
ure 3D). Taken together, these results suggest that the levels of
NEP are critical in determining the success of virus replication.
NEP Splicing Efficiency Is Essential in Coordinating
vRNP Export
Given the critical nature of NEP to virus replication, we next
investigated whether it was the NS splice site itself that was crit-26 Cell Reports 3, 23–29, January 31, 2013 ª2013 The Authorsical for achieving optimal NEP levels. To
this end, we optimized the weak NEP 50
splice site to create a transcript in which
NS1 would be a minor ‘‘readthrough’’
product of the more dominant NEP tran-
script (herein referred to as NS optimal
or NSo). As optimization resulted in a
D12S amino acid substitution, we addi-
tionally produced a parental NS (NSp)
IAV that carries this amino acid change
while maintaining the endogenous, non-optimal, 50 splice site. To confirm that NSo had an inverse
expression profile of NS1:NEP than that of NSp, we performed
a single-cycle growth assay and determined protein levels by
standard western blot (Figure 4A). As anticipated, NSo virus
demonstrated a dramatic reduction in NS1 expression, with a
corresponding increase in NEP, confirming that the quality of
the NS splice site controls levels of NS1 and NEP. Proper
splicing was also confirmed by RT-PCR (Figure S4A).
To ascertain whether the elevated NEP expression would
result in a similar phenotype as the addition of the IAVNEPvector,
we performed multicycle growth curves comparing NSo to NSp.
Because the levels of NS1 produced by NSo were comparable
to the 20T virus in the presence of miR-20 (Figure S4B), we
reasoned that any phenotypic differences between NSo and
NSp could be attributed to NEP overproduction. In agreement
with the NEP overexpression data, NSo replication was signifi-
cantly attenuated,with virus titersdemonstrating a two log reduc-
tion as compared to NSp virus (Figure 4B). To ensure this effect
was indeed independent of NS1, we repeated the experiment
in a NS1 complementing cell line, which also permits replication
of delNS1 IAV (Figure S4C) (Kochs et al., 2009).Multicycle growth
curves performed in the presence of NS1 demonstrated compa-
rable results to unmodified cells, suggesting that the defect in
NSo replication was the direct result of excess NEP (Figure 4C).
Functional levels of NS1 from the NSo virus could also be
confirmed through a lack of Mx1 induction (Figure S4D). Further-
more, NSo virus demonstrated a dramatic loss of replication
in vivo, never accumulating to titers that exceeded 100 pfu/ml.
(Figure 4D). Infection was confirmed by quantitative RT-PCR for
Figure 4. NEP Accumulation Is Essential in
Coordinating Virus Replication
(A) Western blot analysis of WCE from A549 cells
infected with an NS encoding an optimal 50 splice
site (NSo), a parental splice NS (NSp) IAV, or mock
treated for 3, 6, 9, or 12 hr postinfection (HPI).
Immunoblots depict NP, NS1, NEP, and actin.
(B) Multicycle growth curves for NSo and NSp IAV
in A549 cells.
(C) Same as (B) but performed in MDCK-NS1-GFP
cells. Error bars represent mean ± SD of the mean
of samples from independent multicycle growth
curve analyzed in triplicate. LD, limit of detection.
(D) Viral titers from WT C57BL/6 mouse lungs in-
fected intranasally with NSo or NSp.
(E) A549 cells stained for NP expression from NSo
and NSp infection at 5 or 7 hpi and imaged by
fluorescence microscopy. Hoechst dye used to
visualize nuclei.
See also Figure S4.viral NP levels (Figure S4E). Taken together, these data strongly
suggest that the accumulation of NEP is dictated by the splice
site of NS and is critical for proper IAV replication.
NEP Is Required for Coordinating vRNP Export
Because NEP contributes to vRNP export during IAV infection
(O’Neill et al., 1998), we hypothesized that the replication pheno-
types of the NSo and IAV 2A viruses may be the result of
improper timing of vRNP export. To test this hypothesis, localiza-
tion of NP, an essential component of vRNP complexes, was
monitored in lung epithelial cells. These results found that
increasing NEP production through optimization of the 50 splice
site resulted in premature vRNP export, as NP staining could
be observed as early as 5 hpi in response to NSo, whereas
NSp NP staining remained nuclear (Figure 4E). At 7 hpi, NSp
infection began to show signs of vRNP export as 50% of the
infected cells displayedNP staining in the cytoplasm. In contrast,
NSo at the 7 hpi time point demonstrated no cells in which IAV
replication was exclusively nuclear (Figure 4E). Furthermore,
the decreased NEP production of the IAV 2A virus resulted in
a significant delay in vRNP export when compared to wild-type
virus (Figure S4F). These results support the hypothesis that
NEP accumulation alters the localization of vRNPs, and implicate
NEP in orchestrating the timing of IAV infection.Cell Reports 3, 23–2DISCUSSION
Here, we describe five complementing
strategies to probe the molecular contri-
butions of NS1 and NEP during virus
infection. We exploited the endogenous
expression of a ubiquitous miRNA to
selectively target NS1, used siRNAs to
lower NEP expression, overexpressed
NEP by providing it as an extragenic
segment, decreased NEP expression by
coupling it to an inefficient ribosomal rein-
itiation site, andmodified the 50 splice site
to enhance expression of NEP at the ex-pense of NS1. Surprisingly, these strategies all demonstrated
thatNEPaccumulationplaysamoresubstantial roleduring invivo
virus infection than the sustained expression of the IAV inter-
feron antagonist protein, NS1. Given the limited coding capacity
of IAV and the use of only a single promoter on each of the virus
segments, usurping of the splicing machinery provides a clever
method for the virus to control an aspect of its life cycle. Through
the utilization of a poor 50 splice site, the virus generates a
molecular timer, which allows for the slow accumulation of
NEP despite having comparable promoters on each of the eight
segments. As the infection progresses, the virus must switch
from transcription to replication, an event likely triggered by this
accumulation (Perez et al., 2010; Robb et al., 2009). The data pre-
sented here on the manipulation of NEP levels certainly corrobo-
rate that deregulated NEP results in aberrant viral replication.
Lastly, it is noteworthy that splicing has also been implicated in
maintaining the stoichiometric balance of retrovirus components
during infection, although these examples do not extend to
modulating the virus life cycle directly (Katz et al., 1988). Given
that IAV proteins also need to be maintained in a stoichiometric
balance, it was surprising to discover that NS1 is overproduced
by an order ofmagnitude, at least late in infection, with regards to
functionality. This misutilization of viral resources is not an error;
rather, we show that this activity is essential for the accumulation9, January 31, 2013 ª2013 The Authors 27
of NEP to allow the proper timing of virus replication. In this re-
gard, to achieve the slow accumulation of NEP, the virus needs
to overproduce one of its own transcripts. Therefore, as over-
abundance of any polymerase, NP, or receptor components
would alter replication, it is perhaps best suited that NEP accu-
mulation be coupled to NS1 synthesis, where excess message
during infection is inconsequential (or even beneficial). Taken
together, the virus has exploited the predictable nature of the
cell to establish a molecular timer and successfully coordinate
the processes of infection.
EXPERIMENTAL PROCEDURES
Virus Design
Themodified NS segments (A/PR/8/34) have been described previously (Man-
icassamy et al., 2010; Varble et al., 2010). NS1/NEP-miR20T virus was gener-
ated by inserting four perfect complementary miR-20a target sites into the
NS1/NEP intergenic region. NSo and NSp were generated by site-directed
mutagenesis (NSo mutations: G34A and A35G; NSp mutations: G34U and
A35C). VLVs were also described previously (Marsh et al., 2007). In brief,
fibroblasts were transfected with seven bidirectional plasmids (encoding-
PB2, -PB1, -PA, -NP, -NA, -M, and –NS, as well as the corresponding vRNA
segments). In addition, a plasmid expressing the packaging sequence for
segment four that encoded either a scrambled RNA or NEP were also
included. This strategy has been described elsewhere (Gao et al., 2012).
Transfected cells were cocultured with HA-MDCK cells (Marsh et al., 2007).
VLVs were propagated and titered on HA-MDCK cells. For further details,
please refer to Extended Experimental Procedures.
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